Page last updated on April 11, 2024
Lineage Cell Therapeutics, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-07 16:21:06 EST.
Filings
10-K filed on 2024-03-07
Lineage Cell Therapeutics, Inc. filed an 10-K at 2024-03-07 16:21:06 EST
Accession Number: 0000950170-24-027988
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Company Information
| Name | Lineage Cell Therapeutics, Inc. |
| CIK | 0000876343 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Ticker | LCTX - NYSE |
| Website | |
| Category | Non-accelerated filer Smaller reporting company |
| Fiscal Year End | December 30 |